{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-022654","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2021-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.950909+00:00","generated_at":"2026-06-29T01:15:00.743050+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"DiaMedica raises $30M in private placement at $3.92/share for DM199 development","bullets":["Gross proceeds of $30M from sale of 7,653,060 common shares at $3.92 each.","Closing expected September 28, 2021; net proceeds to fund DM199 clinical development including ReMEDy2 trial.","Ten accredited investors participate; shares unregistered but resale registration to be filed with SEC.","Funds also allocated to working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-022654","json":"https://secwatch.observer/filing/0001437749-21-022654.json","markdown":"https://secwatch.observer/filing/0001437749-21-022654.md","text":"https://secwatch.observer/filing/0001437749-21-022654.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774921022654/0001437749-21-022654-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774921022654/dmtp20210926_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T01:15:00.743050+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}